19. Genetic technology
A section of Biology, 9700
Listing 10 of 107 questions
Interferon-alpha (IFN-α) can be produced as a recombinant human protein to treat some types of cancer. The gene IFNA2 codes for IFN-α. One method of producing recombinant IFN-α uses genetically engineered Escherichia coli bacteria that contain recombinant plasmids. Each recombinant plasmid contains: • the gene IFNA2 • three regulatory sequences of the lac operon (promoter, operator and lac• a gene for antibiotic resistance, AMPR. Each of the sequences for the lacI gene and AMPR gene contains its own promoter. As a result, these genes are always expressed in E. coli bacteria that contain this recombinant plasmid. is a diagram of the recombinant plasmid. The promoter regions of the lacI gene and AMPR gene are not shown. IFNA2 AMPR lacI o p e r a t o r p r o m o t e r The start of transcription of the gene IFNA2 by E. coli with the recombinant plasmid shown in needs to be controlled to obtain an optimum yield of IFN-α. Scientists investigated the effect of two inducers of transcription on the production of recombinant IFN-α: • lactose, which is converted to allolactose in E. coli • IPTG, which is a synthetic molecule with a very similar structure to allolactose. IPTG cannot be broken down by E. coli. The scientists grew three cultures of E. coli containing the recombinant plasmid in the same growth medium. The growth medium contained glucose, amino acids, essential vitamins and minerals. The growth medium did not contain lactose. After four hours, either lactose or IPTG at the same concentration was added to two of the cultures of E. coli. As a control, the third culture of E. coli was grown without adding lactose or IPTG. The concentration of recombinant IFN-α in the cultures was measured at different times over a period of 28 hours. The results are shown in . time / hours concentration of IFN-α / μg dm–3 key culture to which IPTG added culture to which lactose added control culture The regulatory sequences of the lac operon contained in the recombinant plasmid are involved in the control of transcription of the gene IFNA2. Explain the role of the gene lacI in the control of transcription of the IFNA2 gene between 0 hours and 4 hours. With reference to , describe the changes in the concentration of recombinant IFN-α in the culture containing IPTG from when IPTG was added at 4 hours to the end of the experiment at 28 hours. Suggest one reason for the difference between the concentration of recombinant IFN-α in the culture at 8 hours in the presence of lactose and the concentration of recombinant IFN-α in the culture at 8 hours in the presence of IPTG. Suggest one reason for the change in the concentration of recombinant IFN-α in the culture containing IPTG from 12 hours to 16 hours. The gene AMPR in the plasmid shown in codes for a protein that provides resistance to the antibiotic ampicillin. Suggest how AMPR allows genetically engineered E. coli containing the recombinant plasmid to be identified. Bacteria can evolve antibiotic resistance through natural processes. Outline how bacteria can evolve to become resistant to antibiotics.
9700_m23_qp_42
THEORY
2023
Paper 4, Variant 2
Genetic technology involving the creation of recombinant DNA can be used to treat different human diseases. These include diseases such as diabetes that may have multiple causes and inherited disorders that are caused by a single gene. Outline two different ways of using recombinant DNA technology to treat these diseases. diabetes single gene disorder A new application of recombinant DNA technology uses the genetic modification of a plant to prevent disease. It aims to prevent the most common source of food-borne disease, which is caused by eating food contaminated with pathogenic Escherichia coli bacteria. Scientists genetically modified edible spinach plants to produce colicins. Colicins are antimicrobial proteins that can kill pathogenic E.coli. Colicins are normally made by other bacteria. An experiment was carried out to test this application by spraying an extract of genetically modified (GM) spinach in buffer solution onto raw meat contaminated with pathogenic E.coli. The meat was stored at 10 °C for varying lengths of time before the numbers of viable pathogenic E.coli bacteria were counted. shows the results. time stored at 10 °C / hours log number of viable bacterial cells per gram of meat no treatment Key: buffer solution only buffer solution plus GM spinach extract With reference to , evaluate the effectiveness of using GM spinach spray on raw meat to prevent food-borne disease. Regulatory authorities may not approve the use of GM spinach spray on raw meat to protect consumers. Discuss the concerns that may stop regulatory authorities approving this application of recombinant DNA technology.
9700_s21_qp_42
THEORY
2021
Paper 4, Variant 2
9700_w23_qp_41
THEORY
2023
Paper 4, Variant 1
9700_w23_qp_43
THEORY
2023
Paper 4, Variant 3
Questions Discovered
107